Business Context and Reporting Period
This Form 8-K filing by Iveda Solutions, Inc. reports on a material event occurring on January 23, 2015, with the report filed on January 28, 2015. The company, incorporated in Nevada, announced the completion of the initial closing of a private placement of Series B Preferred Stock.
Key Financial Metrics and Transaction Details
- Capital Raised: $2,650,000 in gross proceeds from the sale of Series B Preferred Stock.
- Share Price: $10,000 per Series B Preferred Share.
- Conversion Terms: Shares are convertible into common stock at an initial conversion price of $0.75 per share.
- Warrant Issuance:
- Tranche A Warrants: Cover 50% of conversion shares; exercise price $1.00; 18-month term (expires July 23, 2016).
- Tranche B Warrants: Cover 50% of conversion shares; exercise price $1.10; 5-year term (expires January 23, 2020); includes full-ratchet anti-dilution protection.
- Placement Agent Fees: Up to 7% of gross proceeds paid to Northland Securities, Inc., plus warrants equal to up to 5.0% of conversion shares.
Material Changes and Agreements
The primary material change is the entry into a Securities Purchase Agreement dated January 16, 2015, and the subsequent issuance of equity securities. The transaction was exempt from registration under Section 4(2) and Rule 506 of Regulation D. Wolverine Flagship Fund Trading Limited served as the lead investor.
Outlook, Risks, and Contingencies
- Registration Rights: The company agreed to file a registration statement for the resale of conversion shares and warrant shares within 20 calendar days of closing and have it declared effective within 90 days.
- Liquidated Damages: If the registration statement is not filed by the deadline, the company must pay investors 1.5% of the aggregate purchase price as partial liquidated damages, accruing monthly until filed.
- Dilution Risk: Tranche B Warrants contain full-ratchet anti-dilution adjustments, which could significantly increase the number of shares issuable upon future issuances of securities at lower prices.
Investor Verification Checklist
- Verify the exact number of Series B Preferred Shares issued to confirm the total conversion share count.
- Review the Certificate of Designation (Exhibit 3.1) for specific adjustment mechanisms on the conversion price.
- Confirm the status of the Registration Statement filing to assess potential liquidated damages obligations.
- Examine the full text of the Securities Purchase Agreement (Exhibit 10.1) for additional covenants or restrictions.
- Assess the impact of the 7% placement fee and warrant issuance on net proceeds and future dilution.